Ketorolac salt is a newly discovered DDX3 inhibitor to treat oral cancer

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Samal, Sabindra K ^a,b   Routray, Samapika ^c   Veeramachaneni, Ganesh Kumar ^d   Dash, Rupesh ^a   Botlagunta, Mahendran ^d,e  

^a INSTITUTE OF LIFE SCIENCES   (India)

^b MANIPAL UNIVERSITY   (India)

^c SIKSHA O ANUSANDHAN DEEMED TO BE UNIVERSITY   (India)

^d K L UNIVERSITY   (India)

^e Powerdeal Energy Systems (India) Private Limited   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; DDX3X PROTEIN, HUMAN; DEAD BOX PROTEIN; INORGANIC SALT; KETOROLAC;

ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; CARCINOMA, SQUAMOUS CELL; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; FEMALE; HUMAN; LD50; METABOLISM; MOLECULARLY TARGETED THERAPY; MOUSE; PATHOLOGY; PRECLINICAL STUDY; PROCEDURES; TONGUE NEOPLASMS; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL SURVIVAL; DEAD-BOX RNA HELICASES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FEMALE; HUMANS; KETOROLAC; LETHAL DOSE 50; MICE; MICE, INBRED BALB C; MOLECULAR TARGETED THERAPY; SALTS; TONGUE NEOPLASMS; TREATMENT OUTCOME;

EID: 84928739619     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep09982     Document Type: Article

References (49)

1. Umate, P., Tuteja, N. & Tuteja, R. Genome-wide comprehensive analysis of human helicases. Commun. Integr. Biol. 4, 118-137 (2011).
2. Silverman, E., Edwalds-Gilbert, G. & Lin, R. J. DExD/H-box proteins and their partners: helping RNA helicases unwind. Gene. 312, 1-16 (2003).
3. Cordin, O., Banroques, J., Tanner, N. K. & Linder, P. The DEAD-box protein family of RNA helicases. Gene. 367, 17-37 (2006).
4. Rocak, S. & Linder, P. DEAD-box proteins: the driving forces behind RNA metabolism. Nat. Rev. Mol. Cell Biol. 5, 232-241 (2004).
5. de la Cruz, J., Iost, I., Kressler, D. & Linder, P. The p20 and Ded1 proteins have antagonistic roles in eIF4E-dependent translation in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 94, 5201-5206 (1997).
6. Tanner, N. K. & Linder, P. DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol. Cell. 8, 251-262 (2001).
7. Park, S. H., Lee, S. G., Kim, Y. & Song, K. Assignment of a human putative RNA helicase gene, DDX3, to human X chromosome bands p11.3-.p11.23. Cytogenet Cell. Genet. 81, 178-179 (1998).
8. Kim, Y. S., Lee, S. G., Park, S. H. & Song, K. Gene structure of the human DDX3 and chromosome mapping of its related sequences. Mol. Cells 12, 209-214 (2001).
9. Hogbom, M. et al. Crystal structure of conserved domains 1 and 2 of the human DEAD-box helicase DDX3X in complex with the mononucleotide AMP. J. Mol. Biol. 372, 150-159 (2007).
10. Gee, S. L. & Conboy, J. G. Mouse erythroid cells express multiple putative RNA helicase genes exhibiting high sequence conservation from yeast to mammals. Gene. 140, 171-177 (1994).
11. Botlagunta, M. et al. Oncogenic role of DDX3 in breast cancer biogenesis. Oncogene. 27, 3912-3922 (2008).
12. Celia-Terrassa, T. et al. Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells. J. Clin. Invest. 122, 1849-1868 (2012).
13. Sarrio, D. et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res. 68, 989-997 (2008).
14. Talbot, L. J., Bhattacharya, S. D. & Kuo, P. C. Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies. Int. J. Biochem. Mol. Biol. 3, 117-136 (2012).
15. Teicher, B. A. et al. Reduced oxygenation in a rat mammary carcinoma postradiation and reoxygenation with a perflubron emulsion/carbogen breathing. In Vivo. 8, 125-131 (1994).
16. Reynolds, T. Y., Rockwell, S. & Glazer, P. M. Genetic instability induced by the tumor microenvironment. Cancer Res. 56, 5754-5757 (1996).
17. Brizel, D. M. et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res. 56, 941-943 (1996).
18. Semenza, G. L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474-1480 (2000).
19. Botlagunta, M. et al. Expression of DDX3 is directly modulated by hypoxia inducible factor-1 alpha in breast epithelial cells. PLoS. One 6, e17563 (2011).
20. Chang, P. C. et al. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control. Oncogene. 25, 1991-2003 (2006).
21. Chao, C. H. et al. DDX3, a DEAD box RNA helicase with tumor growthsuppressive property and transcriptional regulation activity of the p21waf1/cip1 promoter, is a candidate tumor suppressor. Cancer Res. 66, 6579-6588 (2006).
22. Garbelli, A., Beermann, S., Di Cicco, G., Dietrich, U. & Maga, G. Amotif unique to the human DEAD-box protein DDX3 is important for nucleic acid binding, ATP hydrolysis, RNA/DNA unwinding and HIV-1 replication. PLoS. One 6, e19810 (2011).
23. Yedavalli, V. S., Neuveut, C., Chi, Y. H., Kleiman, L. & Jeang, K. T. Requirement of DDX3 DEAD box RNA helicase for HIV-1 Rev-RRE export function. Cell. 119, 381-392 (2004).
24. Czerninski, R., Amornphimoltham, P., Patel, V., Molinolo, A. A. & Gutkind, J. S. Targeting mammalian target of rapamycin by rapamycin prevents tumor progression in an oral-specific chemical carcinogenesis model. Cancer prevention research 2, 27-36, doi:10.1158/1940-6207.CAPR-08-0147 (2009).
25. Kim, J. L. et al. Hepatitis C virus NS3 RNA helicase domain with a bound oligonucleotide: the crystal structure provides insights into the mode of unwinding. Structure 6, 89-100 (1998).
26. Hodgman, T. C.Anewsuperfamily of replicative proteins. Nature 333, 22-23 (1988).
27. Zhang, P., Zhang, N., Buckwold, V. E. & Hosmane, R. S. Chemical and biological effects of substitution of the 2-position of ring-expanded ('fat') nucleosides containing the imidazo[4, 5-e][1, 3]diazepine-4, 8-dione ring system: the role of electronic and steric factors on glycosidic bond stability and anti-HCV activity. Bioorg. Med. Chem. 15, 4933-4945 (2007).
28. Zhang, N. et al. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus. J. Med. Chem. 46, 4149-4164 (2003).
29. Yedavalli, V. S. et al. Ring expanded nucleoside analogues inhibit RNA helicase and intracellular human immunodeficiency virus type 1 replication. J. Med. Chem. 51, 5043-5051 (2008).
30. Bretner, M., Beckett, T. D., Sood, R. K., Baldisseri, D. M. & Hosmane, R. S. Substrate/inhibition studies of bacteriophage T7 RNA polymerase with the 5'- triphosphate derivative of a ring-expanded ('fat') nucleoside possessing potent antiviral and anticancer activities. Bioorg. Med. Chem. 7, 2931-2936 (1999).
31. Kumar, R., Ujjinamatada, R. K. & Hosmane, R. S. The first synthesis of a novel 5:7:5-fused diimidazodiazepine ring system and some of its chemical properties. Org. Lett. 10, 4681-4684 (2008).
32. Zhang, N. et al. Potent inhibition of NTPase/helicase of the West Nile Virus by ring-expanded ('fat') nucleoside analogues. J. Med. Chem. 46, 4776-4789 (2003).
33. Maga, G. et al. Pharmacophore modeling and molecular docking led to the discovery of inhibitors of human immunodeficiency virus-1 replication targeting the human cellular aspartic acid-glutamic acid-alanine-aspartic acid box polypeptide 3. J. Med. Chem. 51, 6635-6638 (2008).
34. Najda-Bernatowicz, A., Krawczyk, M., Stankiewicz-Drogon, A., Bretner, M. & Boguszewska-Chachulska, A. M. Studies on the anti-hepatitis C virus activity of newly synthesized tropolone derivatives: identification of NS3 helicase inhibitors that specifically inhibit subgenomic HCV replication. Bioorg. Med. Chem. 18, 5129-5136 (2010).
35. Kondaskar, A. et al. Novel, Broad Spectrum Anti-Cancer Agents Containing the Tricyclic 5:7:5-Fused Diimidazodiazepine Ring System. ACS Med. Chem. Lett. 2, 252-256 (2010).
36. Blaylock, R. L. & Maroon, J. Natural plant products and extracts that reduce immunoexcitotoxicity-associated neurodegeneration and promote repair within the central nervous system. Surg. Neurol. Int. 3, 19 (2012).
37. Razzaq, S. N., Khan, I. U., Mariam, I. & Razzaq, S. S. Stability indicating HPLC method for the simultaneous determination of moxifloxacin and prednisolone in pharmaceutical formulations. Chem. Cent. J. 6, 94, doi:10.1186/1752-153X-6-94 (2012).
38. Molodecky, N. A., Panaccione, R., Ghosh, S., Barkema, H. W. & Kaplan, G. G. Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases. Inflamm. Bowel. Dis. 17, 1792-1799, doi:10.1002/ ibd.21511 (2011).
39. Mantovani, A., Allavena, P., Sica, A. & Balkwill, F. Cancer-related inflammation. Nature 454, 436-444, doi:10.1038/nature07205 (2008).
40. Harris, A. L. Hypoxia-a key regulatory factor in tumour growth. Nat. Rev. Cancer 2, 38-47, doi:10.1038/nrc704 (2002).
41. Cosse, J. P. & Michiels, C. Tumour hypoxia affects the responsiveness of cancer cells to chemotherapy and promotes cancer progression. Anticancer Agents Med. Chem. 8, 790-797 (2008).
42. Sun, M., Song, L., Li, Y., Zhou, T. & Jope, R. S. Identification of an antiapoptotic protein complex at death receptors. Cell. Death Differ. 15, 1887-1900 (2008).
43. Retsky, M. et al. NSAID analgesic ketorolac used perioperatively may suppress early breast cancer relapse: particular relevance to triple negative subgroup. Breast Cancer Res. Treat. 134, 881-888, doi:10.1007/s10549-012-2094-5 (2012).
44. Shivakumar, D. W. J.; Wu, Y.; Damm, W.; Shelley, J.; Sherman, W. Prediction of Absolute Solvation Free Energies using Molecular Dynamics Free Energy Perturbation and the OPLS Force Field. Journal of Chemical Theory and Computation 6, 1509-1519 (2010).
45. Halgren, T. A. et al. Glide: a new approach for rapid, accurate docking and scoring. 2. Enrichment factors in database screening. J. Med. Chem. 47, 1750-1759, doi:10.1021/jm030644s (2004).
46. Leelahavanichkul, K. & Gutkind, J. S. Oral and pharyngeal epithelial keratinocyte culture. Methods. Mol. Biol. 945, 67-79, doi:10.1007/978-1-62703-125-7-5 (2013).
47. Dash, R. et al. Apogossypol derivative BI-97C1 (Sabutoclax) targeting Mcl-1 sensitizes prostate cancer cells to mda-7/IL-24-mediated toxicity. Proc. Natl. Acad. Sci. U. S. A. 108, 8785-8790, doi:10.1073/pnas.1100769108 (2011).
48. Beuria, T. K., Singh, P., Surolia, A. & Panda, D. Promoting assembly and bundling of FtsZ as a strategy to inhibit bacterial cell division: a new approach for developing novel antibacterial drugs. Biochem. J. 423, 61-69, doi:10.1042/ BJ20090817 (2009).
49. Beuria, T. K., Santra, M. K. & Panda, D. Sanguinarine blocks cytokinesis in bacteria by inhibiting FtsZ assembly and bundling. Biochemistry 44, 16584-16593, doi:10.1021/bi0507671 (2005).